San Francisco-headquartered telehealth company Hims & Hers is at the heart of one of the biggest controversies during the Super Bowl. Hims & Hers, which has its headquarters in the Marina ...

Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight loss medications. Set to the "This Is America" by Childish Gambino (Donald Glover), the ...

Hims & Hers offers a copycat of the blockbuster weight-loss drug at a fraction of the cost. But it might be a short-lived deal for consumers. This column is from Trendlines, my business newsletter ...

Hims & Hers Health (HIMS) stock moves a notch higher Monday morning after the company's weight-loss drug ad played during the Super Bowl. The commercial's airing raised concerns from health ...

Are you a print subscriber? Activate your account. By Ad Age Staff - 2 hours 11 min ago By Ad Age and Creativity Staff - 2 hours 28 min ago By Jack Neff - 3 hours 14 min ago 4 hours 25 min ago 6 ...

Hims & Hers Health (NYSE:HIMS) has evolved into a healthcare platform with an emphasis on personalized, affordable solutions delivered through a telehealth model. The company has the potential to ...

Hims & Hers sells compounded semaglutide, a version of the active ingredient in Novo Nordisk’s Wegovy and Ozempic drugs. (Hims & Hers Health) Telehealth provider Hims & Hers Health is defending ...

The telehealth company is being criticized for its Super Bowl weight loss commercial. (Hims & Hers via YouTube) ...

Hims & Hers has also moved from a loss-making company to one that is highly profitable. Its net income rose to $75.6 million, while the adjusted EBITDA soared by 317% to $51.1 million. Earnings ahead ...